Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Review · April 21, 2022

Benefit of Sodium-Glucose Cotransporter-2 Inhibitors on Survival Outcome Is Related to the Type of Heart Failure

Diabetes Research and Clinical Practice


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Research and Clinical Practice
Benefit of sodium-glucose cotransporter-2 inhibitors on survival outcome is related to the type of heart failure: A meta-analysis
Diabetes Res. Clin. Pract. 2022 May 01;[EPub Ahead of Print], L Zhao, W Guo, W Huang, L Wang, S Huang

Further Reading